Sign up Canada
Proactive Investors - Run By Investors For Investors

Aequus Pharmaceuticals establishes advisory board in ophthalmology

They are Dr Ike Ahmed who will become chairman and Dr Rosa Braga-Mele, who comes from the University of Toronto.
Aequus Pharmaceuticals establishes advisory board in ophthalmology
The company has established an advisory board

Aequus Pharmaceuticals Inc (CVE:AQS) told investors it had established a strategic advisory board in ophthalmology and appointed its first two members.

They are Dr Ike Ahmed of the Prism Eye Institute, who will become chairman and Dr Rosa Braga-Mele, who comes from the University of Toronto.

This board will help Aequus in determining whether a product can improve patient outcomes, integrate into a clinician's workflow, and navigate the Canadian reimbursement and commercial landscape.

"The formation of our advisory board is another step in our continued commitment to the ophthalmic space in Canada," said Doug Janzen, chairman and CEO of Aequus Pharmaceuticals.

Dr Ahmed has become world renowned for his skills and ground-breaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications

Dr Rosa Braga-Mele is a cataract specialist and educator who speaks frequently at both the national and international level on advanced surgical techniques, innovations in phacoemulsification surgery, complicated cataract cases, and IOL development.

View full AQS profile View Profile

Aequus Pharmaceuticals Inc Timeline

Related Articles

1538160791_petri-dishes.jpg
September 28 2018
The biotech group revealed it had brought in $9.1mln via an oversubscribed placing
car-t cells definition
September 24 2018
The phase I clinical study will evaluate the safety of MaxCyte's MCY-M11 chimeric antigen receptor in people with relapsed or difficult-to-treat ovarian cancer and peritoneal mesothelioma
1540445560_757z468_1537832469_knee.jpg
October 25 2018
The partnership with the US-based network will give Paradigm substantial exposure and access to a large patient pool.
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use